Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor
作者： Ludwig Mehlburger , Marion Wienrich , Martin Michel , Ursula Ebinger
DOI:
关键词:
摘要: This invention describes a new combination for the treatment of bladder function disorders which comprises serotonin- and/or norepinephrine-reuptake inhibitor and beta-3-adrenoceptor agonist.
google.de 参考文章(14)
Masuo Akahane, Yoshinobu Yamazaki, Preventive/remedy for frequent urination and urinary incontinence ,(1997)
Hideyuki Muranaka, Akihito Hirabayashi, Harunobu Mukaiyama, Masaaki Sato, Tetsuro Tamai, Masuo Akahane, Nobuyuki Tanaka, 2-methylpropionic acid derivatives and medicinal compositions containing the same ,(1999)
Kohei Ogawa, Hiroshi Umeno, Novel remedies with the use of beta 3 agonist ,(2001)
Mark A. Muhlhauser, Smriti Iyengar, Karl B. Thor, Methods of treating or preventing interstitial cystitis Official Gazette of the United States Patent and Trademark Office Patents. ,(1997)
Karen Rogosky, Deborah Jorn, New drug combinations ,(2001)
Joseph Herman Krushinski, David Wayne Robertson, David Taiwai Wong, 3-aryloxy-3-substituted propanamines ,(1987)
Donna J. Sellers, Christopher R. Chapple, Russell Chess-Williams, Potential therapeutic targets for treatment of the overactive bladder. World Journal of Urology. ,vol. 19, pp. 307- 311 ,(2001) , 10.1007/PL00007102
Karl-Erik Andersson, The overactive bladder: Pharmacologic basis of drug treatment Urology. ,vol. 50, pp. 74- 84 ,(1997) , 10.1016/S0090-4295(97)00595-5
Amarnath Sharma, Mark J. Goldberg, Benito J. Cerimele, Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor. The Journal of Clinical Pharmacology. ,vol. 40, pp. 161- 167 ,(2000) , 10.1177/00912700022008810
Mark M. Foreman, Treatment of lower urinary tract disorders with selective norepinephrine uptake inhibitors ,(1993)